COVID vaccine response in IBD on different drugs
Vedolizumab SC in CD
Upadacitinib in UC induction and maintenance
Tofacitinib in UC
Infliximab vs conventional therapy in pediatric CD
Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in perianal CD
Ustekinumab in CD
Safety and tolerability of spesolimab in UC
Ustekinumab vs adalimumab in CD
Stop infliximab in CD